Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
90,318,827
-
Total 13F shares
-
69,479,485
-
Share change
-
+3,969,056
-
Total reported value
-
$1,789,961,946
-
Put/Call ratio
-
47%
-
Price per share
-
$25.77
-
Number of holders
-
166
-
Value change
-
+$97,223,694
-
Number of buys
-
83
-
Number of sells
-
77
Institutional Holders of TRAVERE THERAPEUTICS INC - COMMON STOCK (TVTX) as of Q1 2022
As of 31 Mar 2022 TRAVERE THERAPEUTICS INC - COMMON STOCK (TVTX) had 166 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 69,479,485 shares of stock of the company.
Largest 10 holders included ARMISTICE CAPITAL, LLC, RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, MACQUARIE GROUP LTD, BAKER BROS. ADVISORS LP, Deep Track Capital, LP, STATE STREET CORP, and GOLDMAN SACHS GROUP INC.
This table shows 166 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.